Laure Pittet from the University of Melbourne, Australia, presents her Original Article published in Allergy:

Pittet, L.F., Messina, N.L., Gardiner, K., et al. Prevention of infant eczema by neonatal Bacillus Calmette–Guérin vaccination: the MIS BAIR randomised controlled trial. Allergy. 2021. [ Ссылка ]

Research highlights:
• In this randomised controlled trial, a modest reduction in the 12-month cumulative incidence of eczema was observed in infants vaccinated with BCG-Denmark at birth compared with non-BCG-vaccinated infants in the control group.
• This reduction was greater in high-risk infants (two atopic parents).
• The risk difference in high-risk infants was 11.5% (95%CI -21.9% to -1.2%) with a number needed to treat 8.7 (95%CI 4.6 to 83.3).

Follow Allergy on:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]

Like, share and comment on our videos, thank you.
[ Ссылка ]

свернуть